JOYN Advisors’s AstraZeneca AZN Stock Holding History

JOYN Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-254	Closed	-$19K	–	231
2018 Q4	$19K	Hold	254	–	–	﹤0.01%	683
2018 Q3	$20K	Hold	254	–	–	﹤0.01%	678
2018 Q2	$18K	Buy	+254	New	+$18.3K	﹤0.01%	707

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JOYN Advisors's AZN Position: Q1 2019 in Review

JOYN Advisors sold out of AstraZeneca (AZN) in Q1 2019, closing a stake of 254 shares — an estimated $19K sold.

JOYN Advisors first reported a position in AZN in Q2 2018 and held it in 3 quarters. The position peaked at $20K in Q3 2018. 561 funds tracked by Wall St. Rank hold AZN as of Q1 2019.

JOYN Advisors reported no remaining AstraZeneca position as of Q1 2019 after selling out during the quarter.
JOYN Advisors sold 254 AstraZeneca shares in Q1 2019, an estimated $19K.
JOYN Advisors first reported a position in AstraZeneca in Q2 2018 and held it in 3 quarters.
JOYN Advisors's AstraZeneca position peaked at $20K in Q3 2018.
561 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.